Insulin Giants' Antitrust Victory On Shaky Ground At 2nd Circ.
By Jeff Overley · May 2, 2025, 11:07 PM EDT
A major legal triumph for manufacturers of wildly popular medications treating diabetes and obesity suddenly looked precarious Friday at the Second Circuit, where judges sounded open to reviving a proposed class...
To view the full article, register now.